ArticleBlood advances2025

Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era.

Ayotola Fatola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.